Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Federica Pulvirenti, Guido Granata, Gabriella Girelli & Isabella Quinti. (2016) Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies. Expert Review of Clinical Immunology 12:7, pages 725-731.
Read now
Read now
Articles from other publishers (85)
Hui Shi, Jian-Li Qiu, Yan Xu & Lu-Lu Yang. (2023) Experience of IVIG Treatment in an Overweight 14-year-old Child With Kawasaki Disease: A Case Report. Journal of Pediatric Health Care.
Crossref
Crossref
Shu-Na Sun, Yan Zhou, Xing Fu, Yuan-Zheng Zheng, Cao Xie, Guo-You Qin, Fang Liu, Chen Chu, Feng Wang, Cheng-Long Liu, Qing-Tong Zhou, De-Hua Yang, Di Zhu, Ming-Wei Wang & Yong-Hao Gui. (2023) A pilot study of the differentiated landscape of peripheral blood mononuclear cells from children with incomplete versus complete Kawasaki disease. World Journal of Pediatrics.
Crossref
Crossref
A. Emami, S. A. Yeganeh, H. A. Mohammadi & T. Shahbazi. (2023) Diagnostic and Therapeutic Approach to Multisystem Inflammatory Syndrome and Similar Condition. Biology Bulletin Reviews 13:4, pages 301-309.
Crossref
Crossref
Shorooq Banjar, Einav Kadour, Rabea Khoudja, Shaonie Ton‐leclerc, Coralie Beauchamp, Marc Beltempo, Michael H. Dahan, Phil Gold, Isaac Jacques Kadoch, Wael Jamal, Carl Laskin, Neal Mahutte, Shauna Leigh Reinblatt, Camille Sylvestre, William Buckett & Genevieve Genest. (2023) Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss. American Journal of Reproductive Immunology 90:2.
Crossref
Crossref
Lauren Ambler Robinson, Marissa Dale & Mark Gorelik. (2023) Multisystem Inflammatory Syndrome in Children and Kawasaki Disease. Rheumatic Disease Clinics of North America 49:3, pages 661-678.
Crossref
Crossref
Gaia Mancuso, Camillo Bechi Genzano, Alessandra Fierabracci & Georgia Fousteri. (2023) Type 1 diabetes and inborn errors of immunity: Complete strangers or 2 sides of the same coin?. Journal of Allergy and Clinical Immunology 151:6, pages 1429-1447.
Crossref
Crossref
Marco Maglione, Annalisa Barlabà, Michela Grieco, Rosaria Cosimi, Giangiacomo Di Nardo, Giovanni Maria Di Marco, Monica Gelzo, Giuseppe Castaldo, Celeste Tucci, Raffaella Margherita Iodice, Maria Concetta Lonardo, Vincenzo Tipo & Antonietta Giannattasio. (2023) Incomplete Kawasaki Disease with Peripheral Facial Nerve Palsy and Lung Nodules: A Case Report and Literature Review. Children 10:4, pages 679.
Crossref
Crossref
Cathryn Broderick, Shinobu Kobayashi, Maiko Suto, Shuichi Ito & Tohru Kobayashi. (2023) Intravenous immunoglobulin for the treatment of Kawasaki disease. Cochrane Database of Systematic Reviews 2023:1.
Crossref
Crossref
Hironobu Kobayashi, Motoko Y. Kimura, Ichita Hasegawa, Eisuke Suganuma, Yuzuru Ikehara, Kazuhiko Azuma, Toshihiro Ito, Ryota Ebata, Yosuke Kurashima, Yohei Kawasaki, Yuki Shiko, Naoki Saito, Hirotaro Iwase, Youngho Lee, Magali Noval Rivas, Moshe Arditi, Masahiko Zuka, Hiromichi Hamada & Toshinori Nakayama. (2023) Increased Myosin light chain 9 expression during Kawasaki disease vasculitis. Frontiers in Immunology 13.
Crossref
Crossref
E. Sapountzi, L. Fidani, A. Giannopoulos & A. Galli-Tsinopoulou. (2022) Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy. Pediatric Cardiology 44:1, pages 1-12.
Crossref
Crossref
Fuyu Ito, Toshiaki Oharaseki, Daisuke Tsukui, Yoshitaka Kimura, Tamiko Yanagida, Fukuko Kishi, Yoshio Yamakawa, Yosuke Kameoka, Shoichi Suzuki, Kazuko Uno, Osamu Suzuki, Noriko N. Miura, Naohito Ohno, Kei Takahashi, Hajime Kono & Kazuo Suzuki. (2022) Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease. Pediatric Rheumatology 20:1.
Crossref
Crossref
Lorena Elena Melit, Oana Marginean, Tudor Fleșeriu, Alina Negrea, Maria Oana Săsăran, Simina Ghiraghosian-Rusu, Andrei Călin Dragomir, Mirela Oiaga & Carmen Șuteu. (2022) Cardiological Monitoring – A Cornerstone for Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 Outcome: A Case Report and a Review from the Literature. The Journal of Critical Care Medicine 8:4, pages 273-278.
Crossref
Crossref
Yiyi Xiong, Jiawei Xu, Deju Zhang, Shuqin Wu, Zhangwang Li, Jing Zhang, Zhongbin Xia, Panpan Xia, Cai Xia, Xiaoyi Tang, Xiao Liu, Jianping Liu & Peng Yu. (2022) MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring. Frontiers in Immunology 13.
Crossref
Crossref
Diego Estrada-Luna, Elizabeth Carreón-Torres, Susana González-Reyes, María Fernanda Martínez-Salazar, María Araceli Ortiz-Rodríguez, Esther Ramírez-Moreno, José Arias-Rico & Angélica Saraí Jiménez-Osorio. (2022) Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19. Life 12:10, pages 1652.
Crossref
Crossref
Hiromi Yamaguchi, Masaaki Hirata, Kuniya Hatakeyama, Ichiro Yamane, Hisashi Endo, Hiroe Okubo, Yoshimi Nishimura & Yoshiro Nagao. (2022) Hygienic behaviors during the COVID-19 pandemic may decrease immunoglobulin G levels: Implications for Kawasaki disease. PLOS ONE 17:9, pages e0275295.
Crossref
Crossref
Meiqing Yao, Qin He, Manqiong Yang, Zhixiang Wu, Ying Li, Min Kong, Zhijuan Kang, Lu Yi, Yanan Hu, Lihua Huang, Zhuoying Li & Zuocheng Yang. (2022) Association of miR-181c/d gene locus rs8108402 C/T polymorphism with susceptibility to Kawasaki disease in Chinese children. Frontiers in Pediatrics 10.
Crossref
Crossref
Jinwoon Joung, Jun Suk Oh, Jung Min Yoon, Kyung Ok Ko, Gyeong Hee Yoo & Eun Jung Cheon. (2022) A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease. BMC Pediatrics 22:1.
Crossref
Crossref
Yusuke Mimura, Yuka Mimura-Kimura, Radka Saldova, Pauline M. Rudd & Roy Jefferis. (2022) Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation. Frontiers in Immunology 13.
Crossref
Crossref
Hironobu Nakayama, Hiroyasu Inada, Tatsuya Inukai, Kenta Kondo, Kazuyuki Hirai, Tomonari Tsutsumi, Yoshiyuki Adachi, Noriko Nagi-Miura, Naohito Ohno & Koji Suzuki. (2022) Recombinant Human Soluble Thrombomodulin Suppresses Arteritis in a Mouse Model of Kawasaki Disease. Journal of Vascular Research 59:3, pages 176-188.
Crossref
Crossref
Saori Fukui, Mitsuru Seki, Takaomi Minami, Kazuhiko Kotani, Kensuke Oka, Akiko Yokomizo, Daisuke Matsubara, Tomoyuki Sato, Yasuyuki Nozaki, Mari Saito, Yutaka Kikuchi, Kenji Miyamoto, Yukifumi Monden & Takanori Yamagata. (2021) Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial. Pediatric Rheumatology 19:1.
Crossref
Crossref
Xue Fan, Yuhan Zhou, Xin Guo & Mingguo Xu. (2021) Utilizing single-cell RNA sequencing for analyzing the characteristics of PBMC in patients with Kawasaki disease. BMC Pediatrics 21:1.
Crossref
Crossref
Jirayut Jarutach, Supaporn Roymanee & Kanjarut Wongwaitaweewong. (2021) Verification of “Japanese Scoring Systems” to Predict IVIG Resistance and Identification of Predictors for IVIG Resistance in Thai Children with Kawasaki Disease. Pediatric Cardiology 42:8, pages 1799-1804.
Crossref
Crossref
Yanfang P. Zhu, Isaac Shamie, Jamie C. Lee, Cameron J. Nowell, Weiqi Peng, Shiela Angulo, Linh N.N. Le, Yushan Liu, Huilai Miao, Hainan Xiong, Cathleen J. Pena, Elizabeth Moreno, Eric Griffis, Stephanie G. Labou, Alessandra Franco, Lori Broderick, Hal M. Hoffman, Chisato Shimizu, Nathan E. Lewis, John T. Kanegaye, Adriana H. Tremoulet, Jane C. Burns & Ben A. Croker. (2021) Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. Journal of Clinical Investigation 131:20.
Crossref
Crossref
Rebecca A. Porritt, David Zemmour, Masanori Abe, Youngho Lee, Meena NarayananThacyana T. Carvalho, Angela C. GomezDaisy MartinonChintda SantiskulvongMichael C. Fishbein, Shuang Chen, Timothy R. Crother, Kenichi ShimadaMoshe Arditi & Magali Noval Rivas. (2021) NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis. Circulation Research 129:9.
Crossref
Crossref
Jialei Chen, Ping Liu, Wenguang Hu, Yang Xu & Jia Deng. (2021) Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease. Clinical Rheumatology 40:10, pages 4191-4197.
Crossref
Crossref
Paola Di Filippo, Massimiliano Raso, Marta Cacciatore, Roberta Patacchiola, Giulia Renda, Nadia Rossi & Francesco Chiarelli. (2021) Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children. Frontiers in Pediatrics 9.
Crossref
Crossref
Ming-Hsiu Chiang, Hsingjin Eugene Liu & Jinn-Li Wang. (2021) Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review. Archives of Disease in Childhood 106:7, pages 662-668.
Crossref
Crossref
Laura Lopez‐Sanz, Susana Bernal, Luna Jimenez‐Castilla, Ignacio Prieto, Sara La Manna, Sergio Gomez‐Lopez, Luis Miguel Blanco‐Colio, Jesus Egido, Jose Luis Martin‐Ventura & Carmen Gomez‐Guerrero. (2021) Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development. Clinical and Translational Medicine 11:7.
Crossref
Crossref
Cathryn Broderick, Shinobu Kobayashi, Maiko Suto, Shuichi Ito & Tohru Kobayashi. (2021) Intravenous immunoglobulin for the treatment of Kawasaki disease. Cochrane Database of Systematic Reviews 2021:6.
Crossref
Crossref
Jyoti R. Behera, Mukesh K. Jain, Sanjay K. Sahu & Sibabratta Patnaik. (2021) Multisystem Inflammatory Syndrome in Children Associated with COVID-19: An Interim Review. Journal of Pediatric Infectious Diseases.
Crossref
Crossref
Van L. Tran, Sarah Parsons & Andrew Nuibe. (2021) The Trilogy of SARS-CoV-2 in Pediatrics (Part 2): Multisystem Inflammatory Syndrome in Children. The Journal of Pediatric Pharmacology and Therapeutics 26:4, pages 318-338.
Crossref
Crossref
Elaine Liu, Jimmy Gonzalez & Anita Siu. (2021) Use of premedication with intravenous immune globulin in Kawasaki disease: A retrospective review. Pediatric Allergy and Immunology 32:4, pages 750-755.
Crossref
Crossref
Hany Simon Junior, Tania Miyuki Shimoda Sakano, Regina Maria Rodrigues, Adriana Pasmanik Eisencraft, Vitor Emanoel Lemos de Carvalho, Claudio Schvartsman & Amelia Gorete Afonso da Costa Reis. (2021) Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view. Jornal de Pediatria 97:2, pages 140-159.
Crossref
Crossref
Troels Munck Nielsen, Niels Holmark Andersen, Christian Torp-Pedersen, Peter Søgaard & Kristian Hay Kragholm. (2020) Kawasaki disease, autoimmune disorders, and cancer: a register-based study. European Journal of Pediatrics 180:3, pages 717-723.
Crossref
Crossref
Jeremy C. McMurray, Joseph W. May, Madeleine W. Cunningham & Olcay Y. Jones. (2020) Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment. Frontiers in Pediatrics 8.
Crossref
Crossref
Haijian Xing & Gang Tian. (2020) Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease. BMC Immunology 21:1.
Crossref
Crossref
Lorenzo Mambelli, Alessandra Iacono, Giovanna Rametta & Federico Marchetti. (2020) Malattia di Kawasaki: quale dose di immunoglobuline nei bambini grandi?. Medico e Bambino pagine elettroniche 23:9, pages 231-233.
Crossref
Crossref
Chun Zhang, Xuan Zhang, Jia Shen, Xiaotong Lu, Jian Zhang & Sun Chen. (2020) Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study. Mediators of Inflammation 2020, pages 1-9.
Crossref
Crossref
Matthias Walser, Matthias Hermann, Markus HufnagelNikolaus A. Haas, Marcus Fischer, Robert Dalla-Pozza & André Jakob. (2020) Anakinra And Etanercept Combination Treatment in a Child With Severe, Nonresponsive Kawasaki Disease. Pediatric Infectious Disease Journal 39:10, pages e310-e313.
Crossref
Crossref
Vincent Kam Wai Wong. (2020) Editorial overview: New technologies in 2020: Drug resistance. Current Opinion in Pharmacology 54, pages iii-vi.
Crossref
Crossref
Rui Long Zhang, Hang Hong Lo, Cheng Lei, Nikki Ip, Juan Chen & Betty Yuen-Kwan Law. (2020) Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Current Opinion in Pharmacology 54, pages 72-81.
Crossref
Crossref
Chandrika S. Bhat, Latika Gupta, S. Balasubramanian, Surjit Singh & Athimalaipet V. Ramanan. (2020) Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness. Indian Pediatrics 57:10, pages 929-935.
Crossref
Crossref
Danfeng Zhang, Lingjuan Liu, Xupei Huang & Jie Tian. (2020) Insights Into Coronary Artery Lesions in Kawasaki Disease. Frontiers in Pediatrics 8.
Crossref
Crossref
Natasha Nakra, Dean Blumberg, Angel Herrera-Guerra & Satyan Lakshminrusimha. (2020) Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children 7:7, pages 69.
Crossref
Crossref
Magali Noval Rivas & Moshe Arditi. (2020) Kawasaki disease: pathophysiology and insights from mouse models. Nature Reviews Rheumatology 16:7, pages 391-405.
Crossref
Crossref
J. Stowe, N.J. Andrews, P.J. Turner & E. Miller. (2020) The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis. Vaccine 38:32, pages 4935-4939.
Crossref
Crossref
Mark Daniel Hicar. (2020) Antibodies and Immunity During Kawasaki Disease. Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Yusuke Yoshida, Seiichiro Takeshita, Yoichi Kawamura, Takashi Kanai, Yuki Tsujita & Shigeaki Nonoyama. (2020) Enhanced formation of neutrophil extracellular traps in Kawasaki disease. Pediatric Research 87:6, pages 998-1004.
Crossref
Crossref
Hea-Ji Kim, Jae-Jung Kim, Sin Weon Yun, Jeong Jin Yu, Kyung Lim Yoon, Kyung-Yil Lee, Hong-Ryang Kil, Gi Beom Kim, Myung-Ki Han, Min Seob Song, Hyoung Doo Lee, Kee Soo Ha, Young Mi Hong, Gi Young Jang & Jong-Keuk Lee. (2020) Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease. Journal of Human Genetics 65:4, pages 421-426.
Crossref
Crossref
Kanika Arora, Sandesh Guleria, Ankur Kumar Jindal, Amit Rawat & Surjit Singh. (2020) Platelets in Kawasaki disease: Is this only a numbers game or something beyond?. Genes & Diseases 7:1, pages 62-66.
Crossref
Crossref
Priya R. Soni, Magali Noval Rivas & Moshe Arditi. (2020) A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Current Rheumatology Reports 22:2.
Crossref
Crossref
Feng Zhu, Jing Huang, Xuliang Wang, Ping Li, Yaoyao Yan, Yunyun Zheng, Yue'e He, Tingting Wu, Yue Ren & Rongzhou Wu. (2020) The expression and significance of serum caveolin-1 in patients with Kawasaki disease. Chinese Journal of Physiology 63:2, pages 90.
Crossref
Crossref
Meng Xu, Yanfang Jiang, Jinghua Wang, Jinxiang Liu, Congcong Liu, Deying Liu & Sirui Yang. (2019) Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease. BMC Immunology 20:1.
Crossref
Crossref
Alfred Balch, Jacob Wilkes, Emily Thorell, Andrew Pavia, Catherine M.T. Sherwin & Elena Y. Enioutina. (2019) Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals. International Immunopharmacology 76, pages 105868.
Crossref
Crossref
Sang Hun Lee, Kyung Ok Ko, Jae Woo Lim, Jung Min Yoon, Young Hwa Song, Jong Wook Lee & Eun Jung Cheon. (2019) Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis. Rheumatology International 39:11, pages 1955-1960.
Crossref
Crossref
Elif Arslanoglu Aydin, Ilker Ertugrul, Yelda Bilginer, Ezgi Deniz Batu, Hafize Emine Sonmez, Selcan Demir, Zehra Serap Arici, Erdal Sag, Dursun Alehan & Seza Ozen. (2019) The factors affecting the disease course in Kawasaki disease. Rheumatology International 39:8, pages 1343-1349.
Crossref
Crossref
Beatrice Rivalta, Daniele Zama, Giovanni Pancaldi, Elena Facchini, Maria Elena Cantarini, Angela Miniaci, Arcangelo Prete & Andrea Pession. (2019) Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease. Frontiers in Pediatrics 7.
Crossref
Crossref
Jong Gyun Ahn, Yoonsun Bae, Dongjik Shin, Jiho Nam, Kyu Yeun Kim & Dong Soo Kim. (2019) HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Rheumatology 58:5, pages 770-775.
Crossref
Crossref
Moises Rodriguez-Gonzalez, Alvaro A Perez-Reviriego, Ana Castellano-Martinez & Helena M Cascales-Poyatos. (2019) N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease. Biomarkers in Medicine 13:4, pages 307-323.
Crossref
Crossref
Rakesh Kumar Pilania, Ankur Kumar Jindal, Sandesh Guleria & Surjit Singh. (2019) An Update on Treatment of Kawasaki Disease. Current Treatment Options in Rheumatology 5:1, pages 36-55.
Crossref
Crossref
Marco Antonio Yamazaki-Nakashimada, Luisa Berenise Gámez-González, Chiharu Murata, Takafumi Honda, Kumi Yasukawa & Hiromichi Hamada. (2018) IgG levels in Kawasaki disease and its association with clinical outcomes. Clinical Rheumatology 38:3, pages 749-754.
Crossref
Crossref
Satoru Nagata. (2019) Causes of Kawasaki Disease—From Past to Present. Frontiers in Pediatrics 7.
Crossref
Crossref
Lucy Youngmin Eun. (2019) Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?. Korean Circulation Journal 49:2, pages 192.
Crossref
Crossref
Mark C. Ballow. 2019. Clinical Immunology. Clinical Immunology
1143
1153.e1
.
Christopher Beneduce, Elma Kurtagic & Carlos J. Bosques. 2019. Fc Mediated Activity of Antibodies. Fc Mediated Activity of Antibodies
35
62
.
Jun Nakamura, Sachiko Watanabe, Hiroaki Kimura, Motoi Kobayashi, Tadayoshi Karasawa, Ryo Kamata, Fumitake Usui-Kawanishi, Ai Sadatomo, Hiroaki Mizukami, Noriko Nagi-Miura, Naohito Ohno, Tadashi Kasahara, Seiji Minota & Masafumi Takahashi. (2018) Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease. Scientific Reports 8:1.
Crossref
Crossref
Wei-Te Lei, Chien-Yu Lin, Yu-Hsuan Kao, Cheng-Hung Lee, Chao-Hsu Lin, Shyh-Dar Shyur, Kuender-Der Yang & Jian-Han Chen. (2018) The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease: a nationwide population-based matched cohort study. PeerJ 6, pages e4539.
Crossref
Crossref
Linny Kimly Phuong, Nigel Curtis, Peter Gowdie, Jonathan Akikusa & David Burgner. (2017) Treatment Options for Resistant Kawasaki Disease. Pediatric Drugs 20:1, pages 59-80.
Crossref
Crossref
Kyle T. Amber, Jessica Shiu, Katherine Ferris & Sergei A. Grando. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology
401
423
.
Daisuke Okuzaki, Kaori Ota, Shin-ichi Takatsuki, Yukari Akiyoshi, Kazuyuki Naoi, Norikazu Yabuta, Tsutomu Saji & Hiroshi Nojima. (2017) FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease. Scientific Reports 7:1.
Crossref
Crossref
Manjiri Joshi & Robert Tulloh. (2017) Kawasaki disease and coronary artery aneurysms: from childhood to adulthood. Future Cardiology 13:5, pages 491-501.
Crossref
Crossref
S. M. Dietz, D. van Stijn, D. Burgner, M. Levin, I. M. Kuipers, B. A. Hutten & T. W. Kuijpers. (2017) Dissecting Kawasaki disease: a state-of-the-art review. European Journal of Pediatrics 176:8, pages 995-1009.
Crossref
Crossref
Fenggen Yan, Xiumei Mo, Junfeng Liu, Siqi Ye, Xing Zeng & Dacan Chen. (2017) Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling. Molecular Medicine Reports 16:5, pages 7175-7184.
Crossref
Crossref
Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji & Elfriede Pahl. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 135:17.
Crossref
Crossref
Kyung-Yil Lee. (2017) Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy. International Journal of Molecular Sciences 18:2, pages 388.
Crossref
Crossref
Jihoon Kim, Chisato Shimizu, Stephen F. Kingsmore, Narayanan Veeraraghavan, Eric Levy, Andre M. Ribeiro dos Santos, Hai Yang, Jay Flatley, Long Truong Hoang, Martin L. Hibberd, Adriana H. Tremoulet, Olivier Harismendy, Lucila Ohno-Machado & Jane C. Burns. (2017) Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility. PLOS ONE 12:2, pages e0170977.
Crossref
Crossref
Jane C. Burns, Isabelle Koné‐Paut, Taco Kuijpers, Chisato Shimizu, Adriana Tremoulet & Moshe Arditi. (2017) Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki Disease. Arthritis & Rheumatology 69:2, pages 268-276.
Crossref
Crossref
Ming HeZhen ChenMarcy MartinJin ZhangPanjamaporn SangwungBrian WooAdriana H. TremouletChisato ShimizuMukesh K. JainJane C. BurnsJohn Y.-J. Shyy. (2017) miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition. Circulation Research 120:2, pages 354-365.
Crossref
Crossref
Ji Whan Han. (2017) The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?. Korean Circulation Journal 47:2, pages 179.
Crossref
Crossref
Jane W. Newburger. 2017. Kawasaki Disease. Kawasaki Disease
97
101
.
Abdullah Kaplan, Raffaele AltaraAli Eid, George W. BoozFouad A. Zouein. (2016) Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart. Journal of Cardiovascular Pharmacology 68:6, pages 401-413.
Crossref
Crossref
Caroline Galeotti, Srini V. Kaveri, Rolando Cimaz, Isabelle Kon?-Paut & Jagadeesh Bayry. (2016) Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease. Drug Discovery Today 21:11, pages 1850-1857.
Crossref
Crossref
Anita J. Campbell & Jane C. Burns. (2016) Adjunctive therapies for Kawasaki disease. Journal of Infection 72, pages S1-S5.
Crossref
Crossref
Jane W. Newburger, Masato Takahashi & Jane C. Burns. (2016) Kawasaki Disease. Journal of the American College of Cardiology 67:14, pages 1738-1749.
Crossref
Crossref
Raffaele Altara, Ziad Mallat, George W. Booz & Fouad A. Zouein. (2016) The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart. Journal of Immunology Research 2016, pages 1-12.
Crossref
Crossref